<DOC>
	<DOCNO>NCT02018731</DOCNO>
	<brief_summary>The purpose study compare effect L-citrulline metformin combination therapy muscle function force patient Becker muscular dystrophy ( BMD ) .</brief_summary>
	<brief_title>L-citrulline Metformin Becker 's Muscular Dystrophy</brief_title>
	<detailed_description>This single center , not-randomized open study . The study medication consist L-citrulline metformin administer orally ; 5g citrulline 500mg metformin tablet give 3 time daily . Half patient treat metformin first 6 week study . The patient receive initially L-citrulline 6 week , patient treat combination therapy ( metformin L-citrulline ) another 6 week period . The study last 12 week include screen visit 3 visit baseline , week 6 week 12 .</detailed_description>
	<mesh_term>Muscular Dystrophies</mesh_term>
	<mesh_term>Muscular Dystrophy , Duchenne</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>18 year old Molecular immunohistochemical diagnosis BMD ambulant time point screen Participation another therapeutic BMD study within last 3 month Use LArginine , LCitrulline Metformin within last 3 month Other chronic disease relevant limitation renal , liver , heart function accord discretion investigator know hypersensitivity Lcitrulline metformin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Becker 's Muscular dystrophy</keyword>
	<keyword>BMD</keyword>
	<keyword>Metformin</keyword>
	<keyword>L-citrulline</keyword>
</DOC>